Literature DB >> 2610595

Differential modulating effects of retinoic acid on interferon antiviral activity.

C K Ho1, B R Ou, C Y Wang, H Y Chen, T Kuwata.   

Abstract

The effect of retinoic acid (RA) on the antiviral activity of interferons (IFNs) alpha and beta in the U937 and WISH cells was examined to ascertain whether or not RA could reduce the effectiveness of IFN-induced resistance to viral infection. Our results indicate that in the U937 cells, RA (0.1-1.0 microM) had neither enhancing nor suppressive effect on the antiviral activity of IFN-alpha or beta against the Semliki Forest virus (SFV). However, in the WISH cells, RA had different effects on IFNs alpha and beta. Thus, while RA (0.1-50 microM) invariably suppressed the activity of IFN-alpha, it enhanced the action of IFN-beta at low dose (0.1-1.0 microM) but became suppressive at higher concentrations (greater than or equal to 10 microM). Furthermore, higher antiviral activity was consistently obtained when RA (0.1-10 microM) was added prior to either IFN-alpha or IFN-beta comparing to cultures with IFN alone. In addition, direct correlation between antiviral activity and the amplitude of 2-5 oligoadenylate (A) synthetase activity was not observed. These results suggest that modulation of IFN antiviral activity by RA varies with different systems and is dependent on the sequence of treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2610595     DOI: 10.1007/bf01310515

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  30 in total

1.  Antipyretic and antiviral action of vitamin A in Moloney sarcoma virus- and poxvirus-inoculated mice.

Authors:  E Seifter; G Rettura; J Padawer; A A Demetriou; S Levenson
Journal:  J Natl Cancer Inst       Date:  1976-08       Impact factor: 13.506

2.  Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells.

Authors:  A G Hovanessian; J Svab; I Marié; N Robert; S Chamaret; A G Laurent
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

3.  Enhancement of interferon-induced 2-5 oligoadenylate synthetase activity by retinoic acid in human histiocytic lymphoma U937 cells and WISH cells.

Authors:  C K Ho; S Y Wang; B R Ou; M S Shiao; H Y Chen; T Kuwata
Journal:  Differentiation       Date:  1989-03       Impact factor: 3.880

4.  Effect of retinoic acid on the spontaneous and interferon-induced activity of human natural killer cells.

Authors:  J Abb; H Abb; F Deinhardt
Journal:  Int J Cancer       Date:  1982-09-15       Impact factor: 7.396

5.  Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.

Authors:  E C Borden; T F Hogan; J G Voelkel
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

6.  Induction of differentiation of embryonal carcinoma cells by retinol: possible mechanisms.

Authors:  A M Jetten; L M De Luca
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

7.  Combinations of interferon-gamma and retinoic acid or 1 alpha, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937.

Authors:  U Gullberg; E Nilsson; S Einhorn; I Olsson
Journal:  Exp Hematol       Date:  1985-08       Impact factor: 3.084

8.  Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells.

Authors:  A G Hovanessian; E Meurs; L Montagnier
Journal:  J Interferon Res       Date:  1981-02

9.  Interferon-induced changes in the monocyte membrane: inhibition by retinol and retinoic acid.

Authors:  J Rhodes; P Stokes
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.